Mosaic Immunoengineering (CPMV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32 | 54 | 86 | 115 | 6 |
| TOTAL | $55 | $58 | $98 | $142 | $40 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $55 | $58 | $98 | $142 | $40 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200 | 200 | 200 | 200 | 74 |
| Accounts payable and accrued liabilities | 134 | 134 | 138 | 135 | 144 |
| Accrued Expenses | 5,581 | 5,437 | 5,319 | 5,202 | 5,084 |
| TOTAL | $5,915 | $5,770 | $5,657 | $5,537 | $5,301 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,447 | 1,429 | 1,411 | 1,393 | 1,374 |
| TOTAL | $1,447 | $1,429 | $1,411 | $1,393 | $1,374 |
| Total Liabilities | $7,362 | $7,199 | $7,067 | $6,930 | $6,675 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,242 | 7,242 | 7,242 | 7,242 | 7,242 |
| Retained earnings | -9,357 | -9,192 | -9,020 | -8,838 | -8,685 |
| TOTAL | $-7,307 | $-7,142 | $-6,970 | $-6,788 | $-6,635 |
| Total Liabilities And Equity | $55 | $58 | $98 | $142 | $40 |